Datasetsmetadata only
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
19,622Documents
0Full text
2026-09-07Last indexed
Recent documents from this source
- Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome#474768
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors#474767
- Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study#474766
- A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer#474765
- Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases#474764
- CAR-T Cell Immunotherapy for Advanced Lung Cancer#474763
- A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma#474762
- A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma#474761
- Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma#474760
- Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma#474759
- Durvalumab and Tremelimumab in Resectable HCC#474758
- PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer#474757
- Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)#474756
- Neoadjuvant Immunotherapy in Advanced NSCLC#474755
- Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma#474754
- JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma#474753
- Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer#474752
- Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer#474751
- T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers#474750
- Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors#474749
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).